Corvus Pharmaceuticals, Inc. (CRVS)

Recent filings

On September - Sept. 17, 2020

Corvus Pharmaceuticals, Inc. director just declared 0 ownership of the company. - Sept. 15, 2020

Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Sept. 15, 2020

Departure of Directors or Certain - Sept. 11, 2020

On September - Sept. 10, 2020

Corvus Pharmaceuticals Provides Business Update And Reports Second Quarter 2020 Financial Results - July 30, 2020

Corvus Pharmaceuticals, Inc. Just Filed Its Quarterly Report: 3. Net Loss per Shar... - July 30, 2020

Major owner of Corvus Pharmaceuticals, Inc. just disposed of 1,538,062 shares - July 9, 2020

Novo Holdings A just provided an update on activist position in Corvus Pharmaceuticals, Inc. - July 9, 2020

On July - July 7, 2020

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 3,275,616 shares of Corvus Pharmaceuticals, Inc. - June 15, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 12, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 12, 2020

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 3,275,616 shares of Corvus Pharmaceuticals, Inc. - June 12, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 12, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 12, 2020

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 6,767,584 shares of Corvus Pharmaceuticals, Inc. - June 12, 2020

Submission of Matters to a Vote of Security - June 10, 2020

On May - May 29, 2020

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 2,927,560 shares of Corvus Pharmaceuticals, Inc. - May 6, 2020

Securities to be offered to employees in employee benefit plans - April 30, 2020

Corvus Pharmaceuticals Provides Business Update And Reports First Quarter 2020 Financial Results - April 30, 2020

Corvus Pharmaceuticals, Inc. Just Filed Its Quarterly Report: 3. Net Loss per S... - April 30, 2020

OrbiMed Capital GP V LLC just provided an update on activist position in Corvus Pharmaceuticals, Inc. - April 17, 2020

Corvus Pharmaceuticals: Form, Schedule Or Registration Statement No Filing Party: Date Filed: - April 15, 2020

Corvus Pharmaceuticals, Inc. releases salary data. CEO sees compensation fall -19% - April 15, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - March 23, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - March 23, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - March 23, 2020

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 3,275,616 shares of Corvus Pharmaceuticals, Inc. - March 23, 2020

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - March 23, 2020

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 3,275,616 shares of Corvus Pharmaceuticals, Inc. - March 23, 2020

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 6,767,584 shares of Corvus Pharmaceuticals, Inc. - March 23, 2020

Corvus Pharmaceuticals, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - March 20, 2020

Departure of Directors or Certain - March 20, 2020

Corvus Pharmaceuticals, Inc. Just Received a Notice of Effectiveness - March 19, 2020

Registration statement under Securities Act of 1933 - March 9, 2020

Corvus Pharmaceuticals, Inc. Just Filed Its Annual Report: Net Loss per Shar... - March 9, 2020

Corvus Pharmaceuticals Provides Business Update And Reports Fourth Quarter And Full Year 2019 Financial Results - March 5, 2020

Mark N. Lampert just provided an update on share ownership of Corvus Pharmaceuticals, Inc. - Feb. 18, 2020

Mark N. Lampert just provided an update on share ownership of Corvus Pharmaceuticals, Inc. - Feb. 14, 2020

T. ROWE PRICE ASSOCIATES, INC. just provided an update on share ownership of Corvus Pharmaceuticals, Inc. - Feb. 14, 2020

Corvus Pharmaceuticals Presents Updated Clinical Data From Its Phase 1B/2 Clinical Trial Of Ciforadenant At The 2020 American Society Of Clinical Oncology’S Genitourinary Cancers Symposium - Feb. 13, 2020

Sandra J. Horning just provided an update on share ownership of Corvus Pharmaceuticals, Inc. - Feb. 12, 2020

Corvus Pharmaceuticals Presents Updated Clinical Data From Its Phase 1/1B Clinical Trial Of Cpi-818 At The 12Th Annual T-Cell Lymphoma Forum - Feb. 3, 2020

Corvus Pharmaceuticals, Inc.'s Chief Financial Officer was just granted 160,000 options - Dec. 16, 2019

Departure of Directors or Certain - Dec. 16, 2019

Corvus Pharmaceuticals, Inc.'s President and CEO was just granted 320,000 options - Dec. 16, 2019

SVP of Corvus Pharmaceuticals, Inc. was just granted 75,000 options - Dec. 16, 2019

VP of Corvus Pharmaceuticals, Inc. was just granted 50,000 options - Dec. 16, 2019

Corvus Pharmaceuticals, Inc.'s See Remarks was just granted 160,000 options - Dec. 16, 2019

EVP of Corvus Pharmaceuticals, Inc. was just granted 40,000 options - Dec. 16, 2019

VP of Corvus Pharmaceuticals, Inc. was just granted 50,000 options - Dec. 16, 2019

Corvus Pharmaceuticals Presents Preclinical And Initial Clinical Data From The Phase 1/1B Trial Of Cpi-818 At The American Society Of Hematology (Ash) Annual Meeting - Dec. 9, 2019

Corvus Pharmaceuticals, Inc.'s President and CEO just picked up 15,008 shares - Nov. 14, 2019

Entry into a Material Definitive - Nov. 12, 2019

On November - Nov. 8, 2019

Corvus Pharmaceuticals Provides Business Update And Reports Third Quarter 2019 Financial Results - Oct. 29, 2019

Corvus Pharmaceuticals, Inc.'s President and CEO just picked up 7,500 shares - Aug. 8, 2019

Major owner of Corvus Pharmaceuticals, Inc. just picked up 142,656 shares - Aug. 8, 2019

Major owner of Corvus Pharmaceuticals, Inc. just picked up 142,656 shares - Aug. 8, 2019

Mark N. Lampert just provided an update on share ownership of Corvus Pharmaceuticals, Inc. - Aug. 7, 2019

Corvus Pharmaceuticals, Inc. Just Filed Its Quarterly Report: 3. Net Loss per S... - Aug. 1, 2019

Corvus Pharmaceuticals Provides Business Update And Reports Second Quarter 2019 Financial Results - Aug. 1, 2019

Novo Holdings A just provided an update on activist position in Corvus Pharmaceuticals, Inc. - July 29, 2019

Major owner of Corvus Pharmaceuticals, Inc. just disposed of 1,492,956 shares - July 25, 2019

OrbiMed Capital just provided an update on activist position in Corvus Pharmaceuticals, Inc. - July 2, 2019

Major owner of Corvus Pharmaceuticals, Inc. just picked up 657,344 shares - July 1, 2019

Major owner of Corvus Pharmaceuticals, Inc. just picked up 657,344 shares - July 1, 2019

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 24, 2019

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 24, 2019

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 24, 2019

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 5,967,584 shares of Corvus Pharmaceuticals, Inc. - June 24, 2019

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 3,275,616 shares of Corvus Pharmaceuticals, Inc. - June 24, 2019

Major owner of Corvus Pharmaceuticals, Inc. just declared owning 3,275,616 shares of Corvus Pharmaceuticals, Inc. - June 24, 2019

Corvus Pharmaceuticals, Inc. director was just granted 15,000 options - June 24, 2019

Corvus Pharmaceuticals, Inc.'s President and CEO just picked up 12,000 shares - June 17, 2019

Corvus Pharmaceuticals, Inc.'s President and CEO just picked up 15,212 shares - June 11, 2019

Corvus Pharmaceuticals, Inc.'s Chief Financial Officer just picked up 25,500 shares - June 10, 2019

Securities to be offered to employees in employee benefit plans - May 9, 2019

Corvus Pharmaceuticals Provides Business Update And Reports First Quarter 2019 Financial Results - May 9, 2019

Corvus Pharmaceuticals, Inc. Just Filed Its Quarterly Report: 3. Net Loss per S... - May 9, 2019

Corvus Pharmaceuticals: Form, Schedule Or Registration Statement No Filing Party: Date Filed: - April 24, 2019

Corvus Pharmaceuticals, Inc. releases salary data. CEO sees compensation rise 8% - April 24, 2019

Corvus Pharmaceuticals, Inc. Just Filed Its Annual Report: Net Loss per Shar... - March 7, 2019

Corvus Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results And Provides Business Update - March 7, 2019

Mark N. Lampert just provided an update on share ownership of Corvus Pharmaceuticals, Inc. - Feb. 14, 2019

T. ROWE PRICE ASSOCIATES, INC. just provided an update on share ownership of Corvus Pharmaceuticals, Inc. - Feb. 14, 2019

Corvus Pharmaceuticals: Corvus Presents Updated Biomarker And Clinical Results From Lead Pipeline Programs Cpi-444 And Cpi-006 At Immuno-Oncology 360° Conference - Feb. 6, 2019

Novo Holdings A just provided an update on activist position in Corvus Pharmaceuticals, Inc. - Jan. 31, 2019

Corvus Pharmaceuticals, Inc.'s Chief Medical Officer just declared ownership of no shares of Corvus Pharmaceuticals, Inc. - Jan. 30, 2019

Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Jan. 30, 2019

Corvus Pharmaceuticals, Inc.'s Chief Medical Officer was just granted 210,000 options - Jan. 30, 2019

Corvus Pharmaceuticals, Inc. director just declared ownership of no shares of Corvus Pharmaceuticals, Inc. - Jan. 30, 2019

Corvus Pharmaceuticals Announces Appointment Of New Member Of Board Of Directors And Hiring Of Chief Medical Officer - Jan. 28, 2019

Corvus Pharmaceuticals: Corvus Announces Presentation Of Preclinical Data On Cpi-818, A First-In-Class Covalent Inhibitor Of Itk Targeting T-Cell Lymphomas - Jan. 10, 2019

Corvus Pharmaceuticals: Corvus Announces Enrollment In Second Arm Of Phase 1/1B Dose-Escalation Trial Of Anti-Cd73 Antibody, Cpi-006, Focused On Combination With Cpi-444 Adenosine Antagonist - Jan. 8, 2019

Corvus Pharmaceuticals, Inc.'s President and CEO just picked up 20,000 shares - Dec. 31, 2018

Corvus Pharmaceuticals, Inc.'s Chief Financial Officer just picked up 24,700 shares - Dec. 27, 2018

Corvus Pharmaceuticals, Inc.'s President and CEO just picked up 10,000 shares - Dec. 26, 2018

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. ORBIMED ADVISORS LLC 6,767,584 0.3 June 30, 2020
2. ADAMS STREET PARTNERS LLC 3,275,616 1.9 June 30, 2020
3. Novo A/S 2,927,560 0.5 June 30, 2020
4. BVF INC/IL 1,742,112 0.3 June 30, 2020
5. MILLENNIUM MANAGEMENT LLC 1,192,742 N/A June 30, 2020
6. Sandra J. Horning 1,067,826 N/A March 22, 2016
7. RENAISSANCE TECHNOLOGIES LLC 1,031,900 N/A June 30, 2020
8. MILLENNIUM MANAGEMENT LLC 1,031,759 N/A March 31, 2020
9. BlackRock Inc. 946,378 N/A Dec. 31, 2018
10. EcoR1 Capital, LLC 737,612 0.2 June 30, 2020
11. BlackRock Inc. 669,657 N/A Dec. 31, 2017
12. COWEN GROUP, INC. 576,231 0.1 June 30, 2019
13. VANGUARD GROUP INC 574,227 N/A June 30, 2020
14. VANGUARD GROUP INC 574,227 N/A June 30, 2020
15. VANGUARD GROUP INC 574,227 N/A June 30, 2020
16. VANGUARD GROUP INC 574,227 N/A June 30, 2020
17. VANGUARD GROUP INC 574,227 N/A June 30, 2020
18. VANGUARD GROUP INC 574,227 N/A June 30, 2020
19. VANGUARD GROUP INC 574,227 N/A June 30, 2020
20. VANGUARD GROUP INC 574,227 N/A March 31, 2020
21. VANGUARD GROUP INC 574,227 N/A June 30, 2020
22. VANGUARD GROUP INC 574,227 N/A June 30, 2020
23. VANGUARD GROUP INC 574,227 N/A June 30, 2020
24. VANGUARD GROUP INC 574,227 N/A June 30, 2020
25. VANGUARD GROUP INC 574,227 N/A March 31, 2020
26. VANGUARD GROUP INC 574,227 N/A June 30, 2020
27. VANGUARD GROUP INC 574,091 N/A Sept. 30, 2019
28. VANGUARD GROUP INC 574,091 N/A Sept. 30, 2019
29. VANGUARD GROUP INC 487,636 N/A June 30, 2019
30. BlackRock Advisors LLC 456,117 N/A Sept. 30, 2016
 


Feedback